Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized,double-blind, placebo-controlled, clinical trial.
Author Department
Medicine
Document Type
Article, Peer-reviewed
Publication Date
2-1-2004
Recommended Citation
Opal S, Laterre PF, Abraham E, Francois B, Wittebole X, Lowry S, Dhainaut JF, Warren B, Dugernier T, Lopez A, Sanchez M, Demeyer I, Jauregui L, Lorente JA, McGee W, Reinhart K, Kljucar S, Souza S, Pribble J; Controlled Mortality Trial of Platelet-Activating Factor Acetylhydrolase in Severe Sepsis Investigators. Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized,double-blind, placebo-controlled, clinical trial. Crit Care Med 2004 Feb;32(2):332-41.
COinS